您的位置: 首页 > 农业专利 > 详情页

Substituted indoline derivatives as dengue viral replication inhibitors
专利权人:
Janssen Pharmaceuticals, Inc.; Inc.;Katholieke Universiteit Leuven;Janssen Pharmaceuticals
发明人:
Kesteleyn, Bart Rudolf Romanie,Raboisson, Pierre Jean-Marie Bernard,Bonfanti, Jean-François,Bardiot, Dorothée Alice Marie-Eve,Marchand, Arnaud Didier M.
申请号:
AU2017242894
公开号:
AU2017242894A1
申请日:
2017.03.31
申请国别(地区):
AU
年份:
2018
代理人:
摘要:
The present invention concerns substituted indoline derivatives, methods to prevent or treat dengue viral infections by using said compounds and also relates to said compounds for use as a medicine, more preferably for use as a medicine to treat or prevent dengue viral infections. The present invention furthermore relates to pharmaceutical compositions or combination preparations of the compounds, to the compositions or preparations for use as a medicine, more preferably for the prevention or treatment of dengue viral infections. The invention also relates to processes for preparation of the compounds.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充